ICP
SER icon

Interchange Capital Partners’s Serina Therapeutics SER Stock Holding History

Interchange Capital Partners’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11
Closed – – 1141
2020
Q4 		$0 Buy
+11
New +$634 ﹤0.01% 1237

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Interchange Capital Partners's SER Position: Q1 2021 in Review

Interchange Capital Partners sold out of Serina Therapeutics (SER) in Q1 2021, closing a stake of 11 shares.

Interchange Capital Partners first reported a position in SER in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 36 funds tracked by Wall St. Rank hold SER as of Q1 2021.

  • Interchange Capital Partners reported no remaining Serina Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 11 Serina Therapeutics shares in Q1 2021.
  • Interchange Capital Partners first reported a position in Serina Therapeutics in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Serina Therapeutics position peaked at $0 in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.